Biologic Agents in the Treatment of Psoriasis

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|1|3|193-217

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.1, Iss.3, 2007-11, pp. : 193-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Irritants Agents for the Treatment of Irritant Contact Dermatitis: Clinical and Patent Perspective

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 3, 2012-09 ,pp. : 169-185

Bentham Science Publishers

Access to resources Recommend Favorite

Flavone Analogues as Antimicrobial Agents

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 11, Iss. 1, 2017-08 ,pp. : 53-63

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B Links Keratinocytes and Lymphocytes in the Pathogenesis of Psoriasis

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 1, 2009-01 ,pp. : 40-48

Bentham Science Publishers

Access to resources Recommend Favorite

New Method of Inhibition of Activity of Tumor Necrosis Factor Alpha In Patients with Psoriasis

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 10, Iss. 1, 2016-10 ,pp. : 63-66

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Promising Therapeutic Agents in Multiple Sclerosis

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 3, 2007-11 ,pp. : 218-224

Bentham Science Publishers

Access to resources Recommend Favorite